Evidence map›Paper›PMID 40870473›Full record

SynthesisMedicina (Kaunas, Lithuania)2025

Experimental Evidence of Caffeic Acid's Neuroprotective Activity in Alzheimer's Disease: In Vitro, In Vivo, and Delivery-Based Insights.

Adam Kowalczyk, Carlo Ignazio Giovani Tuberoso, Igor Jerković

Abstract readSystematic Review
In one paragraph

Synthesis in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Optimization and Metabolomic Profiling ofInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Adam KowalczykDepartment of Pharmacognosy and Herbal Medicines, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wrocław, Poland.
Carlo Ignazio Giovani TuberosoUnit of Pharmaceutical, Department of Life and Environmental Sciences, Pharmacological and Nutraceutical Sciences, University of Cagliari, 09042 Monserrato, Italy.ORCID 0000-0002-8097-3333
Igor JerkovićMediterranean Institute for Life Sciences, University of Split, 21000 Split, Croatia.

Funding

Wrocław Medical University, Poland SUBZ.D110.25.050
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer DiseaseCaffeic AcidsNeuroprotective AgentsAnimalsAntioxidantsHumansAntioxidantscaffeic acidCaffeic AcidsNeuroprotective AgentsAlzheimer’s diseasecaffeic aciddrug deliveryin vitroin vivoneuroprotection

Identifiers

PMID40870473
PMCPMC12388763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.